Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

American Rebel Holdings (AREB) Research & Development (2016 - 2025)

American Rebel Holdings (AREB) has disclosed Research & Development for 11 consecutive years, with $648357.0 as the latest value for Q2 2025.

  • On a quarterly basis, Research & Development rose 91.95% to $648357.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $691224.0, a 25.12% increase, with the full-year FY2024 number at $385800.0, up 191.11% from a year prior.
  • Research & Development was $648357.0 for Q2 2025 at American Rebel Holdings, up from $93467.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $648357.0 in Q2 2025 to a low of -$328083.0 in Q4 2024.
  • A 5-year average of $146086.0 and a median of $94587.0 in 2023 define the central range for Research & Development.
  • Biggest YoY gain for Research & Development was 1265.16% in 2024; the steepest drop was 442.8% in 2024.
  • American Rebel Holdings' Research & Development stood at $54573.0 in 2021, then surged by 1000.19% to $600408.0 in 2022, then crashed by 84.06% to $95707.0 in 2023, then crashed by 442.8% to -$328083.0 in 2024, then soared by 297.62% to $648357.0 in 2025.
  • Per Business Quant, the three most recent readings for AREB's Research & Development are $648357.0 (Q2 2025), $93467.0 (Q1 2025), and -$328083.0 (Q4 2024).